Literature DB >> 31335481

Safety and Feasibility of Laparoscopic Pelvic Exenteration for Locally Advanced or Recurrent Colorectal Cancer.

Momoko Ichihara1, Mamoru Uemura1, Masataka Ikeda1,2, Masakazu Miyake1, Takeshi Kato1, Takuya Hamakawa1, Sakae Maeda1, Naoki Hama1, Kazuhiro Nishikawa1, Atsushi Miyamoto1, Michihiko Miyazaki1, Motohiro Hirao1, Mitsugu Sekimoto1.   

Abstract

PURPOSE: Pelvic exenteration (PE) for locally advanced or recurrent colorectal cancer is often used to secure negative resection margins. The aim of this study was to evaluate the feasibility of laparoscopic PE.
MATERIALS AND METHODS: The clinical records of 24 patients (9, open; 15, laparoscopic) who underwent total or posterior PE for locally advanced or recurrent colorectal cancer between July 2012 and April 2016 at Osaka National Hospital were retrospectively reviewed. Operative factors were compared between the 2 groups.
RESULTS: The R0 resection rate was 100% in the laparoscopic group and 89% in the open group. The operative time and the incidence of postoperative complications were not significantly different between the 2 groups. The laparoscopic group showed less intraoperative blood loss (P=0.019), a lower C-reactive protein elevation on postoperative day 7 (P=0.025), and a shorter postoperative hospital stay (P=0.0009).
CONCLUSIONS: Laparoscopic PE is a safe and feasible procedure to reduce postoperative stress.

Entities:  

Mesh:

Year:  2019        PMID: 31335481     DOI: 10.1097/SLE.0000000000000699

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  2 in total

1.  Feasibility of laparoscopic-assisted transanal pelvic exenteration in locally advanced rectal cancer with anterior invasion.

Authors:  T Nonaka; T Tominaga; Y Akazawa; T Sawai; Takeshi Nagayasu
Journal:  Tech Coloproctol       Date:  2020-08-19       Impact factor: 3.781

2.  Combined transabdominal and transperineal endoscopic pelvic exenteration for colorectal cancer: feasibility and safety of a two-team approach.

Authors:  Tetsuro Tominaga; Takashi Nonaka; Akiko Fukuda; Toshio Shiraisi; Shintaro Hashimoto; Masato Araki; Yorihisa Sumida; Terumitsu Sawai; Takeshi Nagayasu
Journal:  Ann Surg Treat Res       Date:  2021-07-29       Impact factor: 1.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.